Microsatellite Stable Relapsed or Refractory Colorectal Cancer
1 competing product in clinical development for Microsatellite Stable Relapsed or Refractory Colorectal Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eFT508 + Avelumab | eFFECTOR Therapeutics | Phase 2 | Completed | 44 |